KZA 0.00% 8.0¢ kazia therapeutics limited

San Antonio Breast Cancer Symposium 8 Dec, page-74

  1. 2,082 Posts.
    lightbulb Created with Sketch. 1651
    Not enough whisky on hand at my place for a Priscilla Brastanious ALLIANCE data read this time Metrader......... She is scheduled to give a presentation though -  probably same as what we have heard before.....but good that after 18 months Paxalisib is still VERY much in play.

    A different story with maybe Nancy Lin presenting on Friday - data on the Kazia/ DF breast brain, embargoed cancer trial. All other brain mets presentations are Friday, so could be Friday, but a guess - and check out 30 DF presentations this week.

    --------------------------------------------------

    More than 30 research studies led by Dana-Farber faculty to be presented

    Physician-researchers from Dana-Farber’s Susan F. Smith Center for Women’s Cancers will present more than 30 research studies at the virtual 43rdSan Antonio Breast Cancer Symposium on December 8-12.





    Column 1 Column 2
    0 Spotlight Poster Discussion 13 – Friday, December 11, 2020: 1:00 pm – 2:15 pm
    1    
    2   Brain Metastases Targets and Treatment
    3 PD13-01[/B] Homologous recombination deficiency represents a new therapeutic strategy for breast cancer brain metastasesCosgrove NS, Varešlija D, Keelan S, Furney S, Carter JM, Hart SN, Yadav S, Hill ADK, Oesterreich S, Lee AV, Couch FJ, Young L. Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland; Genomic Oncology Research Group, Royal College of Surgeons in Ireland, Dub
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.